Experts: FDA staff worried about unfinished work, keeping their jobs
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationAudit/inspectionCareer developmentComplianceGDUFAGenericsGMPLeadershipMedical DevicesOTCPDUFAPharmaceuticalsPublic healthRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)User fees